8/22/2008

Shareholders of SGX Pharmaceuticals approved Eli Lilly and Co.'s $64 million takeover offer, which followed a string of recent acquisitions involving major drugmakers and biotech companies. A spokesman for Lilly said the buyout will allow the company to expand in the San Diego area.

Related Summaries